Diagnosis and treatment of female patients with lung cancer in IV stage

Abstract

The prognosis of lung cancer is unfavorable. Five-year survival is achieved only 13% of patients. Most patients have advanced disease and require palliative treatment. The introduction of targeted therapy for the treatment of lung cancer is an important step associated with delay of disease progression while maintaining good life comfort during treatment. We present the case of a woman, in which the diagnostic difficulties were connected with the peripheral location of lung cancer. After the diagnosis, the patient was treated with erlotinib in the second line.